PURPOSE: The aim of this study was to compare the results of excimer laser
photorefractive keratectomy (PRK) in patients who underwent PRK using the S
ummit Apex (Omnimed) excimer laser in one eye and the Nidek EC-5000 excimer
laser in the other.
METHODS: All consecutive patients who underwent PRK with the Summit Apex la
ser (Omnimed) in one eye and the Nidek laser (EC-5000) in the second and ha
d at least 12 months of follow-up were included in this retrospective study
(n=30). Uncorrected and spectacle-corrected visual acuity, final spherical
equivalent refraction, and grade of subepithelial haze were compared. The
average preoperative spherical equivalent refraction of eyes treated with t
he Summit laser was -6.00 D (range, -2.50 to -8.75 D), and for Nidek treate
d eyes it was -5.57 D (range, -2.50 to -8.80 D).
RESULTS: Forty-seven percent of Summit-treated eyes and 53% of Nidek-treate
d eyes had uncorrected visual acuity of 6/6 or better; 61% of Summit-treate
d eyes and 63% of Nidek-treated eyes had uncorrected visual acuity of 6/7.5
or better; 95% of Summit-treated eyes and 95% of Nidek-treated eyes had un
corrected visual acuity of 6/12 or better (difference not statistically sig
nificant). Seventy-three percent of eyes treated with the Summit laser and
80% of eyes treated with the Nidek laser had a postoperative refraction wit
hin +/-0.50 D of emmetropia; 97% of Summit-treated eyes and 87% of Nidek-tr
eated eyes had a postoperative spherical equivalent refraction within +/-1.
00 D of emmetropia; the difference between the two lasers was not statistic
ally significant, However, the percent of eyes with persistent hyperopia wa
s smaller in the Nidek group after 3 months (P=.0062) and after 6 months (P
=.07) than in the Summit group. Videokeratography was not done.
CONCLUSION: Both lasers were effective with relatively low side effects. No
significant difference was found between the two lasers in postoperative u
ncorrected visual acuity or refractive outcome. Eyes operated with the Nide
k laser had less persistent hyperopia and stabilized earlier.